Citations 2

Combined alkylation and histone deacetylase inhibition with EDO-S101 has significant therapeutic activity against brain tumors in preclinical models

Oncotarget | June 15, 2018 | Volume: 9 | Issue: 46 | Pages: 28155-28164

10.18632/oncotarget.25588 | PMID 29963268

Osteopontin is a multi-faceted pro-tumorigenic driver for central nervous system lymphoma

Oncotarget | April 1, 2016 | Volume: 7 | Issue: 22 | Pages: 32156-32171

10.18632/oncotarget.8537 | PMID 27050077